VibraSense – Peripheral Neuropathy Screening Device

Request Quotation


Facilitating accurate and timely detection of
Diabetic Neuropathy in your patients

Diabetic peripheral neuropathy (DPN) is among the top ten diseases that pose heavy burdens on patients and clinicians.

 85% of amputation cases due to diabetic peripheral neuropathy can be avoided with earlier detection.

Optimally managing diabetic foot disease has been a challenge to clinicians for many years, due to its complex multifactorial aetiology and lack of adequate tools to study the underlying pathology.

  • Nearly 50% of individuals with diabetes will develop peripheral neuropathy during their lifetime.
  • Peripheral neuropathy increases the risk for diabetic foot ulcers and amputations.
  • Vibration perception threshold (VPT) testing is a clinically validated method for early neuropathy detection.



Our new VibraSense Smart Peripheral Neuropathy Screener, Revolutionizing Early Detection and Monitoring of Peripheral Neuropathy.


Peripheral neuropathy is a common complication arising from various medical conditions, particularly diabetes, and often goes unnoticed until considerable damage has occurred. Timely detection and management are crucial to prevent complications. Addressing this challenge, the VibraSense Smart Peripheral Neuropathy Screener emerges as a groundbreaking solution. The VibraSense empowers both patients and healthcare professionals with an innovative approach to early detection and continuous monitoring.

The VibraSense device employs cutting-edge vibratory sensory technology to assess nerve functionality in the extremities. Its non-invasive and user-friendly design enables patients to conveniently conduct regular screenings in the comfort of their homes or doctor rooms. By quantifying vibratory perception thresholds, the device identifies even subtle changes in sensory perception. This allows for the early identification of peripheral neuropathy.

What sets VibraSense apart is its seamless integration with a user-friendly mobile application. The app not only guides users through the screening process but also compiles and tracks results over time. These records can be easily shared with healthcare providers, fostering collaborative and informed decision-making. Moreover, VibraSense offers a comprehensive solution by providing personalized insights and recommendations for lifestyle modifications based on individual results.

Healthcare professionals benefit significantly from the VibraSense platform. The device enhances their ability to remotely monitor patients’ neuropathic status, facilitating timely interventions and reducing the risk of complications. By gaining access to real-time data, clinicians can tailor treatment plans more effectively and ensure optimal patient care.

In summary, the VibraSense Smart Peripheral Neuropathy Screener marks a paradigm shift in peripheral neuropathy management. Through its innovative use of vibratory sensory technology and a user-centric mobile application, it empowers patients to take control of their health while enabling healthcare providers to offer proactive and personalized care. With early detection and continuous monitoring, VibraSense contributes to improved patient outcomes and a higher quality of life for individuals at risk of peripheral neuropathy.



Additional information

Weight 0.500 kg
Dimensions 30 × 10 × 20 cm



DIABETES – Vibrasense – 6 vibration stimuli points

VIBRASENSE – Specifications

Vibrasense – Clinical Validation Assessment of the diagnostic accuracy of Vibrasense®

Counting the cost of preventable diabetes-related lower limb amputations at a KZN Hospital

SEMDSA 2017 Guidelines for the Management of Type 2 diabetes mellitus



Question: How it is different from regular Biothesiometer?
Answer: It is a quick and portable tool, provides more consistent stimulus intended for the screening of diabetic peripheral neuropathy

Question: Can it be used while charging?
Answer: No, it is not designed to work while charging

Question: How long does a single charge last?
Answer: It can Screen up to 70+ patients with a single charge

Question: How long will it take a device to be completely charged
Answer: Up to 5 Hours

Question: How long will it take to interpret the results
Answer: It automatically calculates the average VPT and generates the report immediately

Question: can we monitor the strength of stimulus
Answer: Yes, it has an Onboard display to control the strength of the stimulus applied.